[ad_1]
Photo: Pixabay |
Sopharma AD's business turnover dropped 22% in June compared to the same month in the previous year, reported by the company through the website of the Bulgarian Stock Exchange
The drug producer reported a 2% drop in domestic sales and a 34% decline in sales at the end of the year. ;export. However, it is not clear which markets contributed the most to the result. Investors.bg of Sopharma AD commented that the distribution per month is often dynamic, as the drug orders and volumes delivered are not the same every month.
In the first six months of 2018, Sopharma AD's sales sales production turnover decreased by 8% over the same period of 2017. More exports, including the value decreased by 10%, contributed to the decline, while domestic revenue for the same period decreased by 6%.
According to the company's consolidated report for the first quarter of the year, net profit decreased by a fifth to 13.7 million BGN compared to the first three months of 2017. By comparison , on a non-consolidated basis, the company also recorded a decrease in financial income, but by 7% and a 3% decrease in revenue from product sales
Since the beginning of the year, Sopharma shares AD fell 6.63% at an average price of 4.25 BGN per share
[ad_2]
Source link
